Quantifying the race stratified impact of socioeconomics on graft outcomes in kidney transplant recipients

Transplantation

Volumn 100, Issue 7, 2016, Pages 1550-1557

  Taber, David J ^a,b   Hamedi, Mahsa ^a   Rodrigue, James R ^c   Gebregziabher, Mulugeta G ^a   Srinivas, Titte R ^a   Baliga, Prabhakar K ^a   Egede, Leonard E ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; DACLIZUMAB; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; ARTICLE; BEHAVIOR ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE TITRATION; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; INCOME; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; RACE DIFFERENCE; REPEATED DRUG DOSE; SCORING SYSTEM; SOCIAL ADAPTABILITY INDEX; SOCIAL ADAPTATION; SOCIAL STATUS; SUBSTANCE ABUSE; AGED; ECONOMICS; ETHNOLOGY; GRAFT REJECTION; GRAFT SURVIVAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDY; SOCIAL CLASS; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; AGED; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SOCIAL CLASS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84944339796     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000931     Document Type: Article

References (35)

1. Penner LA, Blair IV, Albrecht TL, et al. Reducing racial health care disparities: A social psychological analysis. Policy Insights Behav Brain Sci. 2014;1:204-212.
2. Young CJ, Kew C. Health disparities in transplantation: Focus on the complexity and challenge of renal transplantation in African Americans. Med Clin North Am. 2005;89:1003-1031.
3. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation-clinically appropriate or due to underuse or overuse N Engl J Med. 2000;343:1537-1544.
4. Opelz G, Mickey MR, Terasaki PI. Influence of race on kidney transplant survival. Transplant Proc. 1977;9:137-142.
5. Scantlebury V, Gjertson D, Eliasziw M, et al. Effect of HLA mismatch in African-Americans. Transplantation. 1998;65:586-588.
6. Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: kidney. Am J Transplant. 2014;14(S1):11-44.
7. Butkus DE, Dottes AL, Meydrech EF, et al. Effect of poverty and other socioeconomic variables on renal allograft survival. Transplantation. 2001;72:261-266.
8. Garg PP, Diener-West M, Powe NR. Reducing racial disparities in transplant activation: whom should we target Am J Kidney Dis. 2001;37: 921-931.
9. Goldfarb-Rumyantzev AS, Sandhu GS, Barenbaum A, et al. Education is associated with reduction in racial disparities in kidney transplant outcome. Clin Transplant. 2012;26:891-899.
10. Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts. overriding effects of HLA matching and socioeconomic factors. N Engl JMed. 1992;327:840-845.
11. Hod T, Goldfarb-Rumyantzev AS. The role of disparities and socioeconomic factors in access to kidney transplantation and its outcome. Ren Fail. 2014;36:1193-1199.
12. Goldfarb-Rumyantzev AS, Rout P, SandhuGS, et al. Social adaptability index predicts overall mortality in patients with diabetes. J Diabetes Complications. 2012;26:44-49.
13. Goldfarb-Rumyantzev AS, Rout P, Sandhu GS, et al. Association between social adaptability index and survival of patients with chronic kidney disease. Nephrol Dial Transplant. 2010;25:3672-3681.
14. Sandhu GS, Khattak M, Rout P, et al. Social adaptability index: Application and outcomes in a dialysis population. Nephrol Dial Transplant. 2011; 26:2667-2674.
15. Goldfarb-Rumyantzev AS, Sandhu GS, Baird BC, et al. Social adaptability index predicts access to kidney transplantation. Clin Transplant. 2011;25:834-842.
16. Garg J, Karim M, Tang H, et al. Social adaptability index predicts kidney transplant outcome: A single-center retrospective analysis. Nephrol Dial Transplant. 2012;27:1239-1245.
17. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713-723.
18. Gebregziabher M, Egede LE, Lynch CP, et al. Effect of trajectories of glycemic control on mortality in type 2 diabetes: A semiparametric joint modeling approach. Am J Epidemiol. 2010;171:1090-1098.
19. YeW, Lin X, Taylor JM. Semiparametricmodeling of longitudinal measurements and time-to-event data-a two-stage regression calibration approach. Biometrics. 2008;64:1238-1246.
20. Li L, Hu B, Greene T. A semiparametric joint model for longitudinal and survival data with application to hemodialysis study. Biometrics. 2009; 65:737-745.
21. Guo X, Carlin BP. Separate and joint modeling longitudinal and event time data using standard computer packages. Am Stat. 2004; 58:16-24.
22. Wang Y, Taylor JMG. Jointly modeling longitudinal and event time data with application to acquired immunodeficiency syndrome. J Am Stat Assoc. 2001;96:895-905.
23. Taylor JM, Yu M, Sandler HM. Individualized predictions of disease progression following radiation therapy for prostate cancer. J Clin Oncol. 2005;23:816-825.
24. Goldfarb-Rumyantzev AS, Koford JK, Baird BC, et al. Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol. 2006;1:313-322.
25. Musgrave CR, Pilch NA, Taber DJ, et al. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013;13:796-801.
26. Arthur T. The role of social networks: A novel hypothesis to explain the phenomenon of racial disparity in kidney transplantation. Am J Kidney Dis. 2002;40:678-681.
27. Taber DJ, Douglass K, Srinivas T, et al. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014;40:19-28.
28. Malat GE, Culkin C, Palya A, et al. African american kidney transplantation survival: The ability of immunosuppression to balance the inherent pre-and post-transplant risk factors. Drugs. 2009;69:2045-2062.
29. Taber DJ, Pilch NA, Bratton CF, et al. Medication errors and adverse drug events in kidney transplant recipients: Incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012;32:1053-1060.
30. Neylan JF. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U. S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation. 1997;64:1277-1282.
31. Pallet N, Thervet E, Alberti C, et al. Kidney transplant in Black recipients: Are African Europeans different from African Americans Am J Transplant. 2005;5:2682-2687.
32. Rudge C, Johnson RJ, Fuggle SV, et al. Renal transplantation in the United Kingdom for patients from ethnic minorities. Transplantation. 2007;83: 1169-1173.
33. Yeates K, Wiebe N, Gill J, et al. Similar outcomes among black and white renal allograft recipients. J Am Soc Nephrol. 2009;20:172-179.
34. McDonald SP, Russ GR. Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand. Nephrology (Carlton). 2003;8:42-48.
35. Malek SK, Keys BJ, Kumar S, et al. Racial and ethnic disparities in kidney transplantation. Transpl Int. 2011;24:419-424.